Arcutis Biotherapeutics, Inc. reports

Company location: Westlake Village, CA
Fiscal year end: 31 December

Arcutis Biotherapeutics, Inc. has filed 834 SEC EDGAR filings since 09 Sep 2019

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 476-500 of 834 matching filings.

Per page

25

Current page

20

4

FORM 4

Filing date: 08 Mar 2023
Reporting date: 06 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 08 Mar 2023
Reporting date: 06 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 08 Mar 2023
Reporting date: 06 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 08 Mar 2023
Reporting date: 06 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 08 Mar 2023
Reporting date: 06 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 06 Mar 2023
Reporting date: 02 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 06 Mar 2023
Reporting date: 02 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 06 Mar 2023
Reporting date: 02 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 06 Mar 2023
Reporting date: 02 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 06 Mar 2023
Reporting date: 02 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 06 Mar 2023
Reporting date: 02 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 06 Mar 2023
Reporting date: 02 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 02 Mar 2023
Reporting date: 28 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 02 Mar 2023
Reporting date: 28 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 02 Mar 2023
Reporting date: 28 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 02 Mar 2023
Reporting date: 28 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 02 Mar 2023
Reporting date: 28 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

S-8 File 333-270136

S-8

Filing date: 28 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 001-39186

10-K

Filing date: 28 Feb 2023
Reporting date: 31 Dec 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-39186

8-K

Filing date: 28 Feb 2023
Reporting date: 28 Feb 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 21 Feb 2023
Reporting date: 15 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 15 Feb 2023
Reporting date: 13 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-91349

SCHEDULE 13G/A, AMENDMENT #2

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-91349

SC 13G/A filing

Filing date: 09 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-91349

SC 13G filing

Filing date: 08 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .